Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer

NCT01007942 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

569

Enrollment

INDUSTRY

Sponsor class

Conditions

HER2/Neu Over-expressing Locally Advanced Breast Cancer
Metastatic Breast Cancer

Interventions

DRUG: everolimus
DRUG: Placebo
DRUG: vinorelbine
DRUG: trastuzumab

Sponsor

Novartis Pharmaceuticals